Oraverse
2 FDA drug recalls involving brand “Oraverse”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-31 | Class II | OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 | Novocol Pharmaceutical of Canada, Inc. |
| 2018-04-13 | Class III | OraVerse (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a box of 10 cartridges of 0.4mg/1.7mL e | Septodont Inc. |